Skip to content
777 Sourcing.

Capability

cell-type selective gene expression

Suppliers
1
States & provinces
1
Countries
1

1 cell-type selective gene expression supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

ALETIRA THERAPEUTICS INCORPORATED

BALTIMORE, MD

Aletira is developing gene therapies that use alternative splicing to control where gene expression occurs. Its selective exon, SELEXON(TM), technology harnesses alternative splicing to enable cell-type selective gene expression in therapeutic constructs. SELEXONs can be incorporated into any gene therapy platform (e.g., AAV) to ensure gene products are expressed in target cells and avoid off-target expression, improving safety, increasing potency, and accelerating development.

AIalternative splicingcomputational biologygene therapy

Compiled from public sources

Related capabilities

Other processes offered by the shops that list cell-type selective gene expression.

Browse all capabilities